Financial reports
Current reports
8-K
Other Events
22 Feb 23
8-K
Entry into a Material Definitive Agreement
16 Feb 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Jan 23
8-K
Departure of Directors or Certain Officers
29 Dec 22
8-K
Good Works II Acquisition Corp. and Direct Biologics, LLC Announce a Definitive Agreement for a Business Combination
13 Oct 22
8-K
Good Works II Acquisition Corp. Announces Letter of Intent for a Business Combination with Direct Biologics, LLC
27 Sep 22
8-K
Departure of Directors or Certain Officers
24 May 22
8-K
Departure of Directors or Certain Officers
23 May 22
8-K
Good Works II Acquisition Corp. Announces Upcoming Automatic Unit Separation
20 Aug 21
8-K
Index to Financial Statements
20 Jul 21
Registration and prospectus
15-12G
Securities registration termination
28 Mar 23
25-NSE
Exchange delisting
15 Mar 23
425
Business combination disclosure
25 Jan 23
425
Business combination disclosure
13 Oct 22
424B4
Prospectus supplement with pricing info
13 Jul 21
8-A12B
Registration of securities on exchange
7 Jul 21
S-1/A
IPO registration (amended)
25 Jun 21
S-1/A
IPO registration (amended)
4 Jun 21
S-1
IPO registration
18 Mar 21
Ownership
SC 13G/A
Walleye Capital LLC
15 Feb 23
SC 13G
Mint Tower Capital Management B.V.
14 Feb 23
SC 13G/A
PERISCOPE CAPITAL INC.
13 Feb 23
SC 13G/A
Polar Asset Management Partners Inc.
10 Feb 23
SC 13G/A
Weiss Asset Management LP
30 Jan 23
SC 13G/A
Magnetar Financial LLC
27 Jan 23
SC 13G/A
HIGHBRIDGE CAPITAL MANAGEMENT LLC
25 Jan 23
4
Douglas Clark Wurth
12 Jul 22
4
FRED S ZEIDMAN
12 Jul 22
4
CARY M GROSSMAN
12 Jul 22